Soulemanian, N., Deleavy, G., Soifer, H., Wang, S., Damha, M., Tiemann, K., and Stein, C.A. “Antisense 2’-fluoro, 2’-deoxyarabino nucleic acids (2’F-ANA) oligonucleotides: In vitro gymnotic silencers of gene expression whose potency is enhanced by fatty acids”, Molecular Therapy-Nucleic Acids, 2012, in press.
Pal, S., Twardowski, P., and Stein, C.A. “Long-term treatment of an octogenarian with castrate resistant prostate cancer (CRPC) with cabazitaxel”, Clinical Genitourinary Cancer, 2012 May 8[Epub ahead of print](PMID22575202).
Soifer, H., Souleimanian, N., Wang, S., Voskresenskiy, A., Collak, F., Cinar, B., and Stein, C.A. “Direct regulation of androgen receptor activity in prostate cancer cells by potent CYP17 inhibitors”, J. Biol. Chem., 2012, (287), 3777-3787.
Michaelson, M.D., Bellmunt, J., Hudes, G., Goel, S., Lee, R., Kantoff, P., Stein, C.A., Lardelli, P., Pardos, I., Kahatt, C., Nieto, A., Cullell-Young, M., Lewis, N., Smith, M. Multicenter phase II trial of trabectin in patients with metastatic castration resistant prostate cancer, Annals of Oncology, 2011, doi:10.1093/annonc/mdr399.
Agarwala, S., Keilholz, U., Gilles, E., Bedikian, A., Wu, J., Kay, R., Stein, C.A., Itri, L., Suciu, S., and Eggermont, A. “LDH correlation with survival in advanced melanoma from two large, randomized trials: Oblimersen (GM301) and EORTC18951”, Eur. J. Cancer, 2009, (45) 1807-1814.
Stein, C.A., Hansen, B., Lai, J., Soifer, H., Wu, S., Voskresenskiy, A., Hoeg, A., Worm, J., Hedtjarn, M., Soulemanian, N., Miller, P., Castanotto, D., Benimetskaya, L., Oerum, H., and Koch, T. “Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfecton reagents”, Nucleic Acids Res. 2009 doi:10.1093/nar/gkp841.
Stein, C.A., Wu, S., Voskresenskiy, A., Zhou, J.-F., Shin, J., Miller, P., and Benimetskaya, L. “G3139, an anti-Bcl-2 antisense oligomer that binds heparin-binding growth factors and collagen I, alters in-vitro endothelial cell growth and tubular morphogenesis”, Clinical Cancer Res., 2009, (15) 2797-2807.
Benimetskaya, L., Wu, S., Voskresenskiy, A., Echart, C., Zhou, J.-F., Shin, J., Iacobelli, M., Richardson, P., Ayyanar, K., and Stein, C.A. “Angiogenesis-alteration by Defibrotide: Implications for its mechanism of action in severe hepatic veno-occlusive disease”, Blood, 2008, (112) 4343-4352. See comment: Lazarus, H, and McCrae, K. “SOS! Defibrotide to the rescue” Blood, 2008, (112) 3924-3925.
Stein, C.A., Goel, S. and Ghavamian, R. “Hepatitis and rhabdomyolysis in a patient with hormone refractory prostate cancer treated with ketoconazole on concurrent lovastatin therapy”, Invest. New Drugs, 2007, (25) 277-278.
Tan, W., Loke, Y.-H., Stein, C.A., Miller, P. and Colombini, M. “Phosphorothioate oligonucleotides block the VDAC channel”, Biophys. J., 2007 (93) 1184-1191.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 09/12.
